ArticleThe Lancet regional health. Europe2025

Safety and efficacy of rotigotine in patients with frontotemporal dementia: a phase 2, double-blind, randomized, placebo-controlled, multicenter trial.

Giacomo Koch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.